by Anna Sauerbier
European Brain Council provides feedback on the Horizon Europe proposals
http://www.braincouncil.eu/activities/news/ebc-provides-feedback-on-the-horizon-europe-proposals/
The FDA designates device aiming to mitigate symptoms of agitation and depression associated with AD as “Breakthrough Device”
AC Immune announces two milestones for ACI-24 vaccine in Alzheimer’s disease and Down Syndrome